Disclosures for "Treatment of Fulminant Cerebellitis with Tocilizumab"
-
Dr. Ballinger has nothing to disclose.
-
Dr. Sandweiss has nothing to disclose.
-
The institution of Dr. Shukla has received research support from Roche.
-
Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
-
Author has nothing to disclose
-
Dr. Fisher has nothing to disclose.